Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease

FHS
April 25, 2024
11:00 am

Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.

Primrose Bio and ExPLoRNA partner to develop mRNA therapies

Primrose Bio’s expertise in engineering high-performance RNA polymerases will aid in enhancing the yield of mRNA synthesis. Credit: Photo-Video Lab/Shutterstock. Primrose Bio has entered a

September 4, 2024

FDA strengthens AI regulation to ensure patient safety and innovation in healthcare

The FDA is adapting regulations to manage AI’s rapid development in healthcare, focusing on patient safety and the life cycle of AI tools. This review

October 17, 2024

Are Paxlovid and Lagevrio Equals?

Both nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio) were associated with a reduction in death during the COVID-19 Omicron era, a large retrospective study of electronic health

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.